By Melissa Bailey

January 30, 2017



Despite a 99 percent failure rate and another major setback last month,

Alzheimer's researchers are plowing ahead with hundreds of experiments - and

a boost in federal money - to try to a crack a deadly disease that has

flummoxed them for decades.


A law passed by Congress in December and signed by President Obama sets

aside $3 billion over 10 years to fund research of brain diseases and

precision medicine, a shot in the arm for Alzheimer's research. The law,

called the 21st Century Cures Act, also includes prize money to encourage

Alzheimer's experiments.